| Particulars |
|
|
|
| Company Name
| Alivus Life Sciences Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
24.55 |
B.V. (₹) |
271.50 |
| Sales(₹ Cr.) |
2,551.83 |
NP (₹ Cr.) |
583.76 |
| NP Var (%) |
21.00 |
Div% |
250.00 |
| CPS(₹) |
53.70 |
EPS (₹) |
47.60 |
| Traded Value(₹ Lakhs) |
92.25 |
52 Week High |
1,224.00 |
| 52 Week Low |
830.00 |
Price BSE |
1,045.00 |
| P/C Ratio |
19.50 |
P/E Ratio |
22.00 |
| Price Vs.BV |
3.85 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
689.12 |
| NP(₹ Cr.) |
162.66 |
NP Var % |
15.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
2,204.90 |
| OPM |
28.73 |
NP |
423.50 |
| NP Var (%) |
21.28 |
EPS |
47.56 |
| PE |
21.97 |
|
|